Beyond both the PD-1 and CTLA-4 axis, a number of additional cell surface receptor-ligand interactions are known to contribute to the complex regulation of T cell functional activation and have been implicated in modulating the tumour immune microenvironment toward either pro-inflammatory and anti-tumour or immunosuppressive and tumour-promoting phenotypes. The gene discussed is CTLA4; the disease is neoplasm.